Quarterly report · Q1

Period2023-01-01 → 2023-03-31
Filed2023-05-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥4.9bn2023-01-01 → 2023-03-31Cons.Net sales
Revenue¥16.9bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥4.0bn2022-01-01 → 2022-03-31Cons.Net sales
Operating income¥851m2023-01-01 → 2023-03-31Cons.Operating income
Operating income¥679m2022-01-01 → 2022-03-31Cons.Operating income
Ordinary income¥961m2023-01-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥2.8bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥824m2022-01-01 → 2022-03-31Cons.Ordinary income
Profit before tax¥820m2023-01-01 → 2023-03-31Cons.Income before income taxes
Profit before tax¥824m2022-01-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥511m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.9bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥563m2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income¥509m2023-01-01 → 2023-03-31Cons.Profit loss
Net income¥559m2022-01-01 → 2022-03-31Cons.Profit loss
Total assets¥26.7bnat 2023-03-31Cons.Assets
Total assets¥26.3bnat 2022-12-31Cons.Assets
Total assets¥24.6bnat 2022-03-31Cons.Total assets (5-year summary)
Total liabilities¥7.2bnat 2023-03-31Cons.Liabilities
Total liabilities¥6.8bnat 2022-12-31Cons.Liabilities
Net assets / equity¥19.5bnat 2023-03-31Cons.Net assets
Net assets / equity¥19.5bnat 2022-12-31Cons.Net assets
Net assets / equity¥18.8bnat 2022-03-31Cons.Net assets (5-year summary)
Cash and deposits¥8.2bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥8.9bnat 2022-12-31Cons.Cash and deposits
EPS (basic)¥7.242023-01-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥26.752022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.932022-01-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥7.222023-01-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.662022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥7.912022-01-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio72.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.1%at 2022-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 42
SegmentItemPeriodValue
Otherother segmentsrevenue2023-01-01 → 2023-03-31¥187m
Otherother segmentsrevenue external2023-01-01 → 2023-03-31¥167m
Otherother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥19m
Otherother segmentssegment profit2023-01-01 → 2023-03-31¥2m
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥24m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥24m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥13m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥140m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥140m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥108m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥791m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥791m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥51m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥3.8bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥3.8bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥5m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥892m
—segment totalrevenue2023-01-01 → 2023-03-31¥4.9bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥4.9bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥24m
—segment totalsegment profit2023-01-01 → 2023-03-31¥838m
Otherother segmentsrevenue2022-01-01 → 2022-03-31¥172m
Otherother segmentsrevenue external2022-01-01 → 2022-03-31¥163m
Otherother segmentsrevenue intersegment2022-01-01 → 2022-03-31¥8m
Otherother segmentssegment profit2022-01-01 → 2022-03-31−¥9m
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-03-31−¥10m
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-03-31−¥10m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31¥5m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥136m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥136m
jpcrp040300-q1r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2022-01-01 → 2022-03-31¥27m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥538m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥538m
jpcrp040300-q1r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2022-01-01 → 2022-03-31−¥95m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2022-01-01 → 2022-03-31¥3.1bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2022-01-01 → 2022-03-31¥3.1bn
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2022-01-01 → 2022-03-31¥2m
jpcrp040300-q1r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2022-01-01 → 2022-03-31¥751m
—segment totalrevenue2022-01-01 → 2022-03-31¥4.0bn
—segment totalrevenue external2022-01-01 → 2022-03-31¥4.0bn
—segment totalrevenue intersegment2022-01-01 → 2022-03-31¥10m
—segment totalsegment profit2022-01-01 → 2022-03-31¥673m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 372
ItemContextValueUnit
Regulations in accordance with which consolidated financial statements have been prepared financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Quarterly consolidated balance sheet (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of income (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of comprehensive income (text)CurrentYTDDurationText · Plus
Notes changes in scope of consolidation or equity method (text)CurrentYTDDurationText · Plus
Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes accounting treatments specific to quarterly financial statements quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Description of fact that quarterly statement of cash flows has not been prepared (text)CurrentYTDDurationText · Plus
Notes regarding dividend (text)Prior1YTDDurationText · Plus
Notes regarding dividend (text)CurrentYTDDurationText · Plus
Notes segment information etc quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Footnotes regarding segment information table (text)Prior1YTDDurationText · Plus
Information about impairment loss of non current assets or goodwill etc for each reportable segment (text)Prior1YTDDurationText · Plus
Footnotes regarding segment information table (text)CurrentYTDDurationText · Plus
Information about impairment loss of non current assets or goodwill etc for each reportable segment (text)CurrentYTDDurationText · Plus
Notes business combinations quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass